CV 0.03%? [Study Per­for­mance]

posted by Helmut Homepage – Vienna, Austria, 2014-06-07 15:52 (3991 d 14:32 ago) – Posting: # 13041
Views: 18,695

Hi Khaoula,

❝ […] the drug is omeprazole, that is a HVDP (in bibliography I read a lot of bioequivalence stydy were CV > 30%)


Agree.

❝ […] CV C max of the study Was very low!!!!!!!!


The 0.03% you stated above are practically impossible. Even if you had only monozygotic multiples in your study (violating the “independence” of IID) there would still be variability of the bioanalytical method as a component of the residual variance. Exceptionally good methods still have a CV of ~2–3%. The lowest CVintra of Cmax I ever have seen was ~7% (more than two orders of magnitude higher than yours). Please check your calculations:

\(CV\% = 100\sqrt{e^{MSE}-1}\), where MSE is obtained from ANOVA/GLM of ln-transformed data.

Avoid Kinetica.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
120 visitors (0 registered, 120 guests [including 11 identified bots]).
Forum time: 06:25 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5